Glucosamine has been used for years to relieve joint pain due to osteoarthritis. Clinical studies have shown that it can help reduce cartilage degradation as well as aid in the rebuilding of cartilage. It has provided much needed relief from pain for millions of...
Nutritioninsight.com recently published the news that TSI Group Ltd gained approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to market the glucosamine we manufacture as a full strength, OTC formulation. Sold in the UK under the brand name...
Consumers Crave Transparency Did you know, according to the website Strategy.com, that the joint health market is expected to increase to more than $14 billion in three years (by 2024)? As the joint health market grows, consumers continue to crave transparency. They...